376 related articles for article (PubMed ID: 36410555)
1. Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
Villard C; Friis-Liby I; Rorsman F; Said K; Warnqvist A; Cornillet M; Kechagias S; Nyhlin N; Werner M; Janczewska I; Hagström T; Nilsson E; Bergquist A
J Hepatol; 2023 Mar; 78(3):604-613. PubMed ID: 36410555
[TBL] [Abstract][Full Text] [Related]
2. Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group.
Venkatesh SK; Welle CL; Miller FH; Jhaveri K; Ringe KI; Eaton JE; Bungay H; Arrivé L; Ba-Ssalamah A; Grigoriadis A; Schramm C; Fulcher AS;
Eur Radiol; 2022 Feb; 32(2):923-937. PubMed ID: 34363134
[TBL] [Abstract][Full Text] [Related]
3. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
[TBL] [Abstract][Full Text] [Related]
4. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
5. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
Trilianos P; Selaru F; Li Z; Gurakar A
Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
[TBL] [Abstract][Full Text] [Related]
6. Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis.
Saca D; Flamm SL
Clin Liver Dis; 2024 Feb; 28(1):183-192. PubMed ID: 37945159
[TBL] [Abstract][Full Text] [Related]
7. Impact on follow-up strategies in patients with primary sclerosing cholangitis.
Bergquist A; Weismüller TJ; Levy C; Rupp C; Joshi D; Nayagam JS; Montano-Loza AJ; Lytvyak E; Wunsch E; Milkiewicz P; Zenouzi R; Schramm C; Cazzagon N; Floreani A; Liby IF; Wiestler M; Wedemeyer H; Zhou T; Strassburg CP; Rigopoulou E; Dalekos G; Narasimman M; Verhelst X; Degroote H; Vesterhus M; Kremer AE; Bündgens B; Rorsman F; Nilsson E; Jørgensen KK; von Seth E; Cornillet Jeannin M; Nyhlin N; Martin H; Kechagias S; Wiencke K; Werner M; Beretta-Piccoli BT; Marzioni M; Isoniemi H; Arola J; Wefer A; Söderling J; Färkkilä M; Lenzen H;
Liver Int; 2023 Jan; 43(1):127-138. PubMed ID: 35535655
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
[TBL] [Abstract][Full Text] [Related]
9. Cholangioscopy with narrow-band imaging in patients with primary sclerosing cholangitis undergoing ERCP.
Azeem N; Gostout CJ; Knipschield M; Baron TH
Gastrointest Endosc; 2014 May; 79(5):773-779.e2. PubMed ID: 24206748
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
11. Utility of MRCP in surveillance of primary sclerosing cholangitis associated hepatobiliary malignancy: 15 year experience at a single institution in Ontario, Canada.
Nair AV; Macdonald DB; Kelly EM; Satheesh S; Venugopalan P; Soman DK
Clin Imaging; 2022 Jan; 81():47-53. PubMed ID: 34598005
[TBL] [Abstract][Full Text] [Related]
12. Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret.
Zenouzi R; Liwinski T; Yamamura J; Weiler-Normann C; Sebode M; Keller S; Lohse AW; Schramm C;
Aliment Pharmacol Ther; 2018 Jul; 48(2):169-178. PubMed ID: 29741240
[TBL] [Abstract][Full Text] [Related]
13. Inter-reader agreement of interpretation of radiological course of bile duct changes between serial follow-up magnetic resonance imaging/3D magnetic resonance cholangiopancreatography of patients with primary sclerosing cholangitis.
Grigoriadis A; Morsbach F; Voulgarakis N; Said K; Bergquist A; Kartalis N
Scand J Gastroenterol; 2020 Feb; 55(2):228-235. PubMed ID: 32024405
[No Abstract] [Full Text] [Related]
14. Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis.
Lee JJ; Schindera ST; Jang HJ; Fung S; Kim TK
Abdom Radiol (NY); 2017 Dec; 42(12):2898-2908. PubMed ID: 28951947
[TBL] [Abstract][Full Text] [Related]
15. Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation.
Majeed A; Castedal M; Arnelo U; Söderdahl G; Bergquist A; Said K
Scand J Gastroenterol; 2018 Jan; 53(1):56-63. PubMed ID: 28990806
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A
Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
18. Cholangiocarcinoma and high-grade dysplasia in young patients with primary sclerosing cholangitis.
Liu R; Cox K; Guthery SL; Book L; Witt B; Chadwick B; Adler DG
Dig Dis Sci; 2014 Sep; 59(9):2320-4. PubMed ID: 24748183
[TBL] [Abstract][Full Text] [Related]
19. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
20. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
